Inhibition of platelet aggregation and of experimental thrombosis by sudoxicam.
D000244:Adenosine Diphosphate / Q000378:metabolism; D000284:Administration, Oral; D000577:Amides / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001792:Blood Platelets / Q000378:metabolism; D004285:Dogs; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D008954:Models, Biological; D010973:Platelet Adhesiveness / Q000187:drug effects*; D011817:Rabbits; D013710:Tendons; D013843:Thiazines / Q000008:administration & dosage / Q000494:pharmacology*; D013844:Thiazoles / Q000008:administration & dosage / Q000494:pharmacology; D013927:Thrombosis / Q000517:prevention & control*; D013997:Time Factors; D014020:Tissue Extracts / Q000494:pharmacology
D000577:Amides; D000893:Anti-Inflammatory Agents; D013843:Thiazines; D013844:Thiazoles; D014020:Tissue Extracts; D000244:Adenosine Diphosphate